PFVIX Fees and Costs — Pacific Funds Large-Cap Value, Class R6
Data updated: 2021-02-24
The net expense ratio is 0.65%: a 0.55% management fee plus 0.57% other expenses, less a 0.47% fee waiver. There are no sales loads or redemption fees. In fiscal 2020 the fund paid $5K in broker commissions, 0.0255% of average net assets, and portfolio turnover was 53%.
PFVIX Fees and Expenses
Annual operating expenses and sales charges of PFVIX. Prospectus, as of March 31, 2020.
| Annual operating expenses | |
|---|---|
| Management fee | 0.55% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.57% |
| Gross expense ratio | 1.12% |
| Fee waiver | −0.47% |
| Net expense ratio | 0.65% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
PFVIX Costs Over Time
On $10,000 invested in PFVIX, assuming 5% a year before costs, total costs come to $425 over 5 years, cutting the return by 0.71% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.65%) | $68 | $214 | $372 |
| Trading costs (broker commissions) | $3 | $8 | $15 |
| Lost growth on money paid in costs | $0 | $11 | $39 |
| Total costs | $71 | $233 | $425 |
| Value after costs | $10,429 | $11,343 | $12,338 |
| Impact on return, per year | 0.71% | 0.71% | 0.71% |
PFVIX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2020.
- Explicit cost rate (commissions ÷ average net assets): 0.0255%
- Total broker commissions: $5K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 53%
- Securities lending: none during the year
PFVIX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Stifel, Nicolaus & Company, Incorporated | $1K | 28.91% |
| JEFFERIES LLC | $952 | 21.79% |
| Raymond James & Associates, Inc. | $489 | 11.19% |
| J.P. MORGAN SECURITIES LLC | $463 | 10.60% |
| GOLDMAN SACHS & CO. LLC | $320 | 7.32% |
| RBC CAPITAL MARKETS, LLC | $276 | 6.32% |
| Cowen and Company, LLC | $255 | 5.84% |
| Stuart Frankel & Co., Incorporated | $140 | 3.20% |
| KEYBANC CAPITAL MARKETS, INC. | $107 | 2.45% |
| SIDOTI & COMPANY, LLC | $104 | 2.38% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.